C07D 239/34
One oxygen atom
C07D239/34 (One oxygen atom) appears on 1,277 US grants and 942 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,277
- Published applications
- 942
- Assignees
- 525
- Inventors
- 3,992
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 16 | 0 |
| 1978 | 6 | 0 |
| 1979 | 12 | 0 |
| 1980 | 8 | 0 |
| 1981 | 12 | 0 |
| 1982 | 11 | 0 |
| 1983 | 9 | 0 |
| 1984 | 10 | 0 |
| 1985 | 11 | 0 |
| 1986 | 16 | 0 |
| 1987 | 17 | 0 |
| 1988 | 16 | 0 |
| 1989 | 27 | 0 |
| 1990 | 26 | 0 |
| 1991 | 32 | 0 |
| 1992 | 39 | 0 |
| 1993 | 38 | 0 |
| 1994 | 46 | 0 |
| 1995 | 51 | 0 |
| 1996 | 25 | 0 |
| 1997 | 24 | 0 |
| 1998 | 36 | 0 |
| 1999 | 31 | 0 |
| 2000 | 30 | 0 |
| 2001 | 25 | 1 |
| 2002 | 29 | 33 |
| 2003 | 27 | 32 |
| 2004 | 33 | 39 |
| 2005 | 14 | 42 |
| 2006 | 18 | 32 |
| 2007 | 23 | 25 |
| 2008 | 16 | 36 |
| 2009 | 27 | 51 |
| 2010 | 23 | 38 |
| 2011 | 33 | 39 |
| 2012 | 34 | 47 |
| 2013 | 39 | 42 |
| 2014 | 43 | 44 |
| 2015 | 50 | 48 |
| 2016 | 36 | 48 |
| 2017 | 50 | 54 |
| 2018 | 38 | 47 |
| 2019 | 26 | 32 |
| 2020 | 34 | 36 |
| 2021 | 20 | 32 |
| 2022 | 23 | 32 |
| 2023 | 17 | 29 |
| 2024 | 15 | 38 |
| 2025 | 12 | 29 |
| 2026 | 12 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Inhibitors of ret16 Jun 2026US 12,655,128 B2Rigel Pharmaceuticals, Inc.
- HSD17B13 inhibitors and uses thereof2 Jun 2026US 12,643,858 B2Inipharm, Inc.
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathways26 May 2026US 12,637,450 B2Global Cancer Technology Inc.
- Broad spectrum anti-cancer compounds19 May 2026US 12,630,527 B2The Regents of the University of California
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
- Amide compounds as activators of the potassium channels kv7.2/kv7.3 useful in the treatment of cns and pns disorders6 Aug 2026US 2026/0226007 A1Angelini Pharma S.P.A.
- Urea compounds as activators of potassium channels kv7.2/7.3 useful in the treatment of cns and pns disorders23 Jul 2026US 2026/0207563 A1Angelini Pharma S.P.A.
- Hydrazide compound and agricultural/horticultural fungicide16 Jul 2026US 2026/0198493 A1Nippon Soda Co., Ltd.
- Compositions and methods for treating radiation induced brain tissue damage9 Jul 2026US 2026/0191857 A1Antinous Technology Company Limited
Most cited
By later US patents
- Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces208US 5,650,234 ASurface Engineering Technologies, Division of Innerdyne, Inc. · 1997
- Pyrimidine derivatives189US 5,260,440 AShionogi Seiyaku Kabushiki Kaisha · 1993
- Nitrogen-containing aromatic derivatives135US 7,253,286 B2Eisai Co., Ltd. · 2007
- Mediators of hedgehog signaling pathways, compositions and uses related thereto127US 6,545,005 B1Curtis, Inc. · 2003
- Substituted benzoylphenylureas compounds useful as pesticides123US 4,847,258 ACiba-Geigy Corporation · 1989